Page last updated: 2024-08-16

ranitidine and Carcinoma, Lobular

ranitidine has been researched along with Carcinoma, Lobular in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Daling, JR; Li, CI; Malone, KE; Mathes, RW; Porter, PL	1

Other Studies

1 other study(ies) available for ranitidine and Carcinoma, Lobular

Article	Year
Relationship between histamine2-receptor antagonist medications and risk of invasive breast cancer. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2008, Volume: 17, Issue:1 Topics: Aged; Anti-Ulcer Agents; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Case-Control Studies; Cimetidine; Famotidine; Female; Histamine H2 Antagonists; Humans; Middle Aged; Neoplasm Invasiveness; Ranitidine; Risk Factors; Washington	2008

Article

Year

Relationship between histamine2-receptor antagonist medications and risk of invasive breast cancer.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2008, Volume: 17, Issue:1

Topics: Aged; Anti-Ulcer Agents; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Case-Control Studies; Cimetidine; Famotidine; Female; Histamine H2 Antagonists; Humans; Middle Aged; Neoplasm Invasiveness; Ranitidine; Risk Factors; Washington

2008